2009
DOI: 10.1002/anie.200906122
|View full text |Cite
|
Sign up to set email alerts
|

Total Synthesis of Spirastrellolide F Methyl Ester—Part 2: Macrocyclization and Completion of the Synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(13 citation statements)
references
References 52 publications
0
12
1
Order By: Relevance
“…Several fragment syntheses of 141 have been reported by De Brabander, clxxviii Forsyth, clxxix Paterson, clxxx Hsung, clxxxi Furstner, clxxxii , Smith, clxxxiii and Phillips. clxxxiv Total syntheses of spirastrellolide A methyl ester and spirastrellolide F methyl ester have been accomplished by the Paterson clxxxv and Furstner clxxxvi groups, respectively.…”
Section: Selected Examplesmentioning
confidence: 99%
“…Several fragment syntheses of 141 have been reported by De Brabander, clxxviii Forsyth, clxxix Paterson, clxxx Hsung, clxxxi Furstner, clxxxii , Smith, clxxxiii and Phillips. clxxxiv Total syntheses of spirastrellolide A methyl ester and spirastrellolide F methyl ester have been accomplished by the Paterson clxxxv and Furstner clxxxvi groups, respectively.…”
Section: Selected Examplesmentioning
confidence: 99%
“…To date, the Yamaguchi protocol and variations have been used in more than 340 synthetic applications, including eightmembered lactones 257−259 such as topsentolide A1 260 and solandelactone E; 261−263 nine-membered halicholactone 264 519 and epilachnene and congeners. 520 Some of these applications are illustrated in Figure 9.…”
Section: Macrolactonization Through the Formation Of A Mixed Anhydridmentioning
confidence: 99%
“…Protein phosphatases are recognized as potential targets in drug discovery for Parkinson’s disease, Alzheimer’s disease, and specifically tumor suppressors for blood cancers. Due to these features, spirastrellolide is potentially a lead compound for anticancer therapeutics. This activity has inspired a significant amount of interest from the synthetic community resulting in elegant total syntheses and synthetic strategies toward this natural product. Despite its potency, a comprehensive biological evaluation of spirastrellolide A has not been undertaken, perhaps due to limited supplies from these studies or from natural sources. , Inspired by the eribulin work, we envisioned that SAR studies on simplified analogues of the marine macrolide spirastrellolide A might help identify the pharmacophore.…”
Section: Introductionmentioning
confidence: 99%